Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Combination of Polybacterial MV140 and Candida albicans V132 as a Potential Novel Trained Immunity-Based Vaccine for Genitourinary Tract Infections.

Frontiers in immunology - 1 Jan 2020

Martin-Cruz Leticia, Sevilla-Ortega Carmen, Benito-Villalvilla Cristina, Diez-Rivero Carmen M, Sanchez-Ramón Silvia, Subiza José Luis, Palomares Oscar

Abstract excerpt

Recurrent urinary tract infections (RUTIs) and recurrent vulvovaginal candidiasis (RVVCs) represent major healthcare problems with high socio-economic impact worldwide. Antibiotic and antifungal prophylaxis remain the gold standard treatments for RUTIs and RVVCs, contributing to the massive rise of antimicrobial resistance, microbiota alterations and co-infections. Therefore, the development of novel vaccine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Bacterial
Share to Antigens, Fungal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bacterial Infections

Share to Bacterial Vaccines

Share to Candidiasis, Vulvovaginal

Share to Coculture Techniques

Share to Urinary Tract Infections

Share to Vaccination

Source

Open in PubMed Open full text

Identifiers

PMID: 33552074
DOI: 10.3389/fimmu.2020.612269
PMCID: PMC7858650

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Combination of Polybacterial MV140 and Candida albicans V132 as a Potential Novel Trained Immunity-Based Vaccine for Genitourinary Tract Infections.PMID 33552074Read ↗

Next-generation Candida albicans recombinant Als3p and Hyr1p dual antigen vaccine for invasive Candida infectionsSemantic proximity Read ↗

A Novel LNP-based Chlamydia subunit vaccine formulation that induces Th1 responses without upregulating IL-17 provides equivalent protection in mice as formulations that induced IL-17 and Th1 cytokinesSemantic proximity Read ↗

Intranasal immunization with CPAF combined with cyclic-di-AMP induces a memory CD4 T cell response and reduces bacterial burden following intravaginal infection with <i>Chlamydia muridarum</i>Semantic proximity Read ↗

Development of vaccines for Candida albicans: fighting a skilled transformer.Semantic proximity Read ↗

DnaJ, A Promising Vaccine Candidate Against Ureaplasma Urealyticum InfectionSemantic proximity Read ↗

In silico Design of a Multivalent Vaccine Against Candida albicansSemantic proximity Read ↗

A multi‐subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN‐γ+ CMI responses protects against a genital infection in minipigsSemantic proximity Read ↗

Optimization of an Experimental Vaccine to Prevent <i>Escherichia coli</i> Urinary Tract InfectionSemantic proximity Read ↗

Unveiling immune interference: How the dendritic cell response to co-infection with <i>Aspergillus fumigatus</i> is modulated by human cytomegalovirus and its virokine CMVIL-10Semantic proximity Read ↗

Glycyrrhiza uralensis polysaccharides as a DC-based Vaccine Adjuvant: Enhanced Immunotherapy Combined with PD-1 BlockadeSemantic proximity Read ↗

What Do We Know About and What Could Be the Strategy Adopted to Treat Mucormycosis on Post-COVID-19 Cases? Is It an Adjuvant Nanomaterial?Semantic proximity Read ↗

Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.